MED28 increases the colony‑forming ability of breast cancer cells by stabilizing the ZNF224 protein upon DNA damage

Cho,Jin Gu; Lim,Key‑Hwan; Park,Sang Gyu

doi:10.3892/ol.2017.7718

MED28 increases the colony‑forming ability of breast cancer cells by stabilizing the ZNF224 protein upon DNA damage

Authors:
- Jin Gu Cho
- Key‑Hwan Lim
- Sang Gyu Park
View Affiliations

Affiliations: Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, Gyeonggi‑do 443‑749, Republic of Korea
Published online on: December 29, 2017 https://doi.org/10.3892/ol.2017.7718
Pages: 3147-3154

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The regulation of gene expression by transcription factors serves a critical function in cell proliferation. Zinc‑finger protein 224 (ZNF224), a Krüppel‑associated‑box‑containing zinc finger protein, is known to serve a crucial function in integrating the transcriptional co‑factors that activate transcriptional regulation pathways in the cell. A previous study demonstrated that ZNF224 enhances cell proliferation by downregulating the expression of p21 and p53. The present study identified mediator complex subunit 28 (MED28) as a potential binding partner for ZNF224; this was confirmed by co‑immunoprecipitation and a surface plasmon resonance assay. Additionally, the KRAB domain at the N‑terminal of ZNF224 interacts with the MED domain of MED28. Bimolecular fluorescence complementation analysis revealed that ZNF224 associates with MED28 in the nucleus. In addition, ZNF224 was rapidly degraded upon treatment with the DNA‑damaging agent camptothecin (CPT). Transient overexpression of MED28 inhibited the CPT‑mediated degradation of ZNF224, resulting in increased colony formation by MCF‑7 cells. The molecular mechanisms that underlie the biological outcomes of MED28 expression have not yet been fully elucidated. The present study provides molecular evidence for the function of ZNF224 and MED28 in the DNA‑damage response.

View Figures

View References

1	Lord CJ and Ashworth A: The DNA damage response and cancer therapy. Nature. 481:287–294. 2012. View Article : Google Scholar : PubMed/NCBI
2	Jackson SP and Bartek J: The DNA-damage response in human biology and disease. Nature. 461:1071–1078. 2009. View Article : Google Scholar : PubMed/NCBI
3	Weinert T: DNA damage and checkpoint pathways: Molecular anatomy and interactions with repair. Cell. 94:555–558. 1998. View Article : Google Scholar : PubMed/NCBI
4	Zhou BB and Elledge SJ: The DNA damage response: Putting checkpoints in perspective. Nature. 408:433–439. 2000. View Article : Google Scholar : PubMed/NCBI
5	Roos WP, Thomas AD and Kaina B: DNA damage and the balance between survival and death in cancer biology. Nat Rev Cancer. 16:20–33. 2016. View Article : Google Scholar : PubMed/NCBI
6	Vitale I, Galluzzi L, Castedo M and Kroemer G: Mitotic catastrophe: A mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 12:385–392. 2011. View Article : Google Scholar : PubMed/NCBI
7	Freed-Pastor W and Prives C: Targeting mutant p53 through the mevalonate pathway. Nat Cell Biol. 18:1122–1124. 2016. View Article : Google Scholar : PubMed/NCBI
8	Lane DP: Cancer. p53, guardian of the genome. Nature. 358:15–16. 1992. View Article : Google Scholar : PubMed/NCBI
9	Stracquadanio G, Wang X, Wallace MD, Grawenda AM, Zhang P, Hewitt J, Zeron-Medina J, Castro-Giner F, Tomlinson IP, Goding CR, et al: The importance of p53 pathway genetics in inherited and somatic cancer genomes. Nat Rev Cancer. 16:251–265. 2016. View Article : Google Scholar : PubMed/NCBI
10	Muller PA and Vousden KH: Mutant p53 in cancer: New functions and therapeutic opportunities. Cancer Cell. 25:304–317. 2014. View Article : Google Scholar : PubMed/NCBI
11	Menendez D, Inga A and Resnick MA: The expanding universe of p53 targets. Nat Rev Cancer. 9:724–737. 2009. View Article : Google Scholar : PubMed/NCBI
12	Cho JG, Park S, Lim CH, Kim HS, Song SY, Roh TY, Sung JH, Suh W, Ham SJ, Lim KH and Park SG: ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a. Oncotarget. 7:31177–31190. 2016. View Article : Google Scholar : PubMed/NCBI
13	Malik S and Roeder RG: The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet. 11:761–772. 2010. View Article : Google Scholar : PubMed/NCBI
14	Allen BL and Taatjes DJ: The mediator complex: A central integrator of transcription. Nat Rev Mol Cell Biol. 16:155–166. 2015. View Article : Google Scholar : PubMed/NCBI
15	Lu M, Sartippour MR, Zhang L, Norris AJ and Brooks MN: Targeted inhibition of EG-1 blocks breast tumor growth. Cancer Biol Ther. 6:936–941. 2007. View Article : Google Scholar : PubMed/NCBI
16	Lee MF, Pan MH, Chiou YS, Cheng AC and Huang H: Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. J Agric Food Chem. 59:11853–11861. 2011. View Article : Google Scholar : PubMed/NCBI
17	Huang CY, Chou YH, Hsieh NT, Chen HH and Lee MF: MED28 regulates MEK1-dependent cellular migration in human breast cancer cells. J Cell Physiol. 227:3820–3827. 2012. View Article : Google Scholar : PubMed/NCBI
18	Yu MA, Cho JG, Kim KI, Jo YJ, Sung JH, Yang HB and Park SG: Generation of med28 specific monoclonal antibodies. Monoclon Antib Immunodiagn Immunother. 34:30–35. 2015. View Article : Google Scholar : PubMed/NCBI
19	Florio F, Cesaro E, Montano G, Izzo P, Miles C and Costanzo P: Biochemical and functional interaction between ZNF224 and ZNF255, two members of the Kruppel-like zinc-finger protein family and WT1 protein isoforms. Hum Mol Genet. 19:3544–3556. 2010. View Article : Google Scholar : PubMed/NCBI
20	Lu M, Zhang L, Maul RS, Sartippour MR, Norris A, Whitelegge J, Rao JY and Brooks MN: The novel gene EG-1 stimulates cellular proliferation. Cancer Res. 65:6159–6166. 2005. View Article : Google Scholar : PubMed/NCBI
21	Lupo A, Cesaro E, Montano G, Zurlo D, Izzo P and Costanzo P: KRAB-Zinc finger proteins: A repressor family displaying multiple biological functions. Curr Genomics. 14:268–278. 2013. View Article : Google Scholar : PubMed/NCBI
22	Myers LC and Kornberg RD: Mediator of transcriptional regulation. Annu Rev Biochem. 69:729–749. 2000. View Article : Google Scholar : PubMed/NCBI
23	Otto T and Sicinski P: Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 17:93–115. 2017. View Article : Google Scholar : PubMed/NCBI
24	Kastan MB and Bartek J: Cell-cycle checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
25	Sperka T, Wang J and Rudolph KL: DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol. 13:579–590. 2012. View Article : Google Scholar : PubMed/NCBI
26	Gokduman K: Strategies targeting DNA topoisomerase i in cancer chemotherapy: Camptothecins, nanocarriers for camptothecins, organic non-camptothecin compounds and metal complexes. Curr Drug Targets. 17:1928–1939. 2016. View Article : Google Scholar : PubMed/NCBI
27	Medugno L, Florio F, De Cegli R, Grosso M, Lupo A, Costanzo P and Izzo P: The Krüppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 co-repressor protein. Gene. 359:35–43. 2005. View Article : Google Scholar : PubMed/NCBI
28	Cesaro E, De Cegli R, Medugno L, Florio F, Grosso M, Lupo A, Izzo P and Costanzo P: The Kruppel-like zinc finger protein ZNF224 recruits the arginine methyltransferase PRMT5 on the transcriptional repressor complex of the aldolase A gene. J Biol Chem. 284:32321–32330. 2009. View Article : Google Scholar : PubMed/NCBI
29	Montano G, Ullmark T, Jernmark-Nilsson H, Sodaro G, Drott K, Costanzo P, Vidovic K and Gullberg U: The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein. Leuk Res. 40:60–67. 2016. View Article : Google Scholar : PubMed/NCBI
30	Harada Y, Kanehira M, Fujisawa Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y and Katagiri T: Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 70:5829–5839. 2010. View Article : Google Scholar : PubMed/NCBI
31	Lee TH, Lwu S, Kim J and Pelletier J: Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor. J Biol Chem. 277:44826–44837. 2002. View Article : Google Scholar : PubMed/NCBI
32	Moore M, Klug A and Choo Y: Improved DNA binding specificity from polyzinc finger peptides by using strings of two-finger units. Proc Natl Acad Sci USA. 98:pp. 1437–1441. 2001; View Article : Google Scholar : PubMed/NCBI
33	Salmon SE: Human tumor colony assay and chemosensitivity testing. Cancer Treat Rep. 68:117–125. 1984.PubMed/NCBI
34	Gur-Dedeoglu B, Konu O, Bozkurt B, Ergul G, Seckin S and Yulug IG: Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues. Oncol Res. 17:353–365. 2009. View Article : Google Scholar : PubMed/NCBI
35	Zhang L, Maul RS, Rao J, Apple S, Seligson D, Sartippour M, Rubio R and Brooks MN: Expression pattern of the novel gene EG-1 in cancer. Clin Cancer Res. 10:3504–3508. 2004. View Article : Google Scholar : PubMed/NCBI